BioSpace News Archive

Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research. [20-September-2019] BOSTON , Sept. 20, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyu

Bayer will present new data from the company’s expanding oncology business at the European Society for Medical Oncology (ESMO) Congress 2019, taking place September 27 to October 1 in Barcelona, Spain.

Pioneering Organic Chemist, Professor of Medicinal Chemistry First to Isolate Cannabinoids Leading to the Breakthrough Discoveries of the Endocannabinoid System, Total Synthesis of THC in 1960s

The global pharyngeal cancer therapeutics market is expected to post a CAGR of over 6% during the period 2019-2023, according to the latest market research report by Technavio

KCI, an Acelity Company, today announced the availability of PREVENA RESTOR BELLA•FORM™ System, specifically designed to manage post-operative incisions, as well as the surrounding soft tissue envelope following surgical procedures, to stabilize the incision and surrounding surgical area, reduce edema and help improve healing.

Sono-Tek Corporation (OTCQX:SOTK) is pleased to announce that Sono-Tek has entered into an agreement with Avior Bio Incorporated for Sono-Tek ultrasonic coating equipment to be used in the Avior product development and future manufacturing process.

Arrowhead Pharmaceuticals Inc. announced that as an inducement to entering into employment with the Company, on September 13, 2019, the Compensation Committee of the Board of Directors approved “inducement” grants to 17 new employees under Rule 5635 of the NASDAQ Marketplace Rules.

Encompass Health Corporation (NYSE: EHC) today issued notice for redemption of $400 million of the outstanding principal balance of its 5.75% senior notes due 2024 (the “2024 Notes”).

Vizient, Inc. today announced the winners of their Bernard A. Birnbaum, MD, Quality Leadership Award and Ambulatory Care Quality and Accountability Award for 2019.